89 related articles for article (PubMed ID: 12960088)
1. The WT1 Wilms' tumor suppressor gene: a novel target for insulin-like growth factor-I action.
Bentov I; LeRoith D; Werner H
Endocrinology; 2003 Oct; 144(10):4276-9. PubMed ID: 12960088
[TBL] [Abstract][Full Text] [Related]
2. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
Sarfstein R; Werner H
J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
[TBL] [Abstract][Full Text] [Related]
3. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
6. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
9. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.
Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D
Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
Castillo AI; Tolon RM; Aranda A
Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of WT1.
Haber DA; Englert C; Maheswaran S
Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
[TBL] [Abstract][Full Text] [Related]
14. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
[TBL] [Abstract][Full Text] [Related]
15. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
16. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
17. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
[TBL] [Abstract][Full Text] [Related]
18. Induction of p21 by the Wilms' tumor suppressor gene WT1.
Englert C; Maheswaran S; Garvin AJ; Kreidberg J; Haber DA
Cancer Res; 1997 Apr; 57(8):1429-34. PubMed ID: 9108440
[TBL] [Abstract][Full Text] [Related]
19. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.
Shahrabani-Gargir L; Pandita TK; Werner H
Endocrinology; 2004 Dec; 145(12):5679-87. PubMed ID: 15345673
[TBL] [Abstract][Full Text] [Related]
20. Analysis of WT1 target gene expression in stably transfected cell lines.
Thäte C; Englert C; Gessler M
Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
